JP2022513049A5 - - Google Patents

Info

Publication number
JP2022513049A5
JP2022513049A5 JP2021526563A JP2021526563A JP2022513049A5 JP 2022513049 A5 JP2022513049 A5 JP 2022513049A5 JP 2021526563 A JP2021526563 A JP 2021526563A JP 2021526563 A JP2021526563 A JP 2021526563A JP 2022513049 A5 JP2022513049 A5 JP 2022513049A5
Authority
JP
Japan
Prior art keywords
item
polypeptide
scaffold protein
protein
biologically active
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2021526563A
Other languages
English (en)
Japanese (ja)
Other versions
JP2022513049A (ja
JP7538795B2 (ja
Filing date
Publication date
Priority claimed from PCT/US2018/061679 external-priority patent/WO2019099942A1/en
Application filed filed Critical
Priority claimed from PCT/US2019/033629 external-priority patent/WO2020101740A1/en
Publication of JP2022513049A publication Critical patent/JP2022513049A/ja
Publication of JP2022513049A5 publication Critical patent/JP2022513049A5/ja
Priority to JP2024077013A priority Critical patent/JP2024097929A/ja
Application granted granted Critical
Publication of JP7538795B2 publication Critical patent/JP7538795B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2021526563A 2018-11-16 2019-05-22 操作された細胞外小胞及びその使用 Active JP7538795B2 (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2024077013A JP2024097929A (ja) 2018-11-16 2024-05-10 操作された細胞外小胞及びその使用

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
USPCT/US2018/061679 2018-11-16
PCT/US2018/061679 WO2019099942A1 (en) 2017-11-17 2018-11-16 Compositions of engineered exosomes and methods of loading luminal exosomes payloads
US201962835430P 2019-04-17 2019-04-17
US62/835,430 2019-04-17
PCT/US2019/033629 WO2020101740A1 (en) 2018-11-16 2019-05-22 Engineered extracellular vesicles and uses thereof

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2024077013A Division JP2024097929A (ja) 2018-11-16 2024-05-10 操作された細胞外小胞及びその使用

Publications (3)

Publication Number Publication Date
JP2022513049A JP2022513049A (ja) 2022-02-07
JP2022513049A5 true JP2022513049A5 (cg-RX-API-DMAC7.html) 2022-05-31
JP7538795B2 JP7538795B2 (ja) 2024-08-22

Family

ID=70732111

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2021526563A Active JP7538795B2 (ja) 2018-11-16 2019-05-22 操作された細胞外小胞及びその使用
JP2024077013A Pending JP2024097929A (ja) 2018-11-16 2024-05-10 操作された細胞外小胞及びその使用

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2024077013A Pending JP2024097929A (ja) 2018-11-16 2024-05-10 操作された細胞外小胞及びその使用

Country Status (28)

Country Link
EP (3) EP4059510B1 (cg-RX-API-DMAC7.html)
JP (2) JP7538795B2 (cg-RX-API-DMAC7.html)
KR (1) KR20210098473A (cg-RX-API-DMAC7.html)
CN (2) CN113286603B (cg-RX-API-DMAC7.html)
AU (1) AU2019378591A1 (cg-RX-API-DMAC7.html)
BR (1) BR112021009231A2 (cg-RX-API-DMAC7.html)
CA (1) CA3119720A1 (cg-RX-API-DMAC7.html)
CL (1) CL2021001278A1 (cg-RX-API-DMAC7.html)
CY (1) CY1124897T1 (cg-RX-API-DMAC7.html)
DK (1) DK3672614T3 (cg-RX-API-DMAC7.html)
EA (1) EA202191334A1 (cg-RX-API-DMAC7.html)
ES (1) ES2907967T3 (cg-RX-API-DMAC7.html)
HR (1) HRP20220020T1 (cg-RX-API-DMAC7.html)
HU (1) HUE057300T2 (cg-RX-API-DMAC7.html)
IL (1) IL283167A (cg-RX-API-DMAC7.html)
LT (1) LT3672614T (cg-RX-API-DMAC7.html)
MA (1) MA49971B1 (cg-RX-API-DMAC7.html)
MD (1) MD3672614T2 (cg-RX-API-DMAC7.html)
MX (1) MX2021005636A (cg-RX-API-DMAC7.html)
PH (1) PH12021551088A1 (cg-RX-API-DMAC7.html)
PL (1) PL3672614T3 (cg-RX-API-DMAC7.html)
PT (1) PT3672614T (cg-RX-API-DMAC7.html)
RS (1) RS62863B1 (cg-RX-API-DMAC7.html)
SG (1) SG11202104956QA (cg-RX-API-DMAC7.html)
SI (1) SI3672614T1 (cg-RX-API-DMAC7.html)
SM (1) SMT202200156T1 (cg-RX-API-DMAC7.html)
TW (2) TWI846697B (cg-RX-API-DMAC7.html)
WO (1) WO2020101740A1 (cg-RX-API-DMAC7.html)

Families Citing this family (39)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2020215010A1 (en) * 2019-04-17 2020-10-22 Codiak Biosciences, Inc. Compositions of exosomes and aav
US20220251200A1 (en) 2019-07-03 2022-08-11 Codiak Biosciences, Inc. Extracellular vesicles targeting t cells and uses thereof
CN114729356A (zh) * 2019-08-14 2022-07-08 科迪亚克生物科学公司 靶向stat6的细胞外囊泡-aso构建体
EP4013872A1 (en) * 2019-08-14 2022-06-22 Codiak BioSciences, Inc. Extracellular vesicles with antisense oligonucleotides targeting kras
EP4013878A1 (en) 2019-08-14 2022-06-22 Codiak BioSciences, Inc. Extracellular vesicle-aso constructs targeting cebp/beta
CN114729327A (zh) 2019-08-14 2022-07-08 科迪亚克生物科学公司 具有stat3反义寡核苷酸的细胞外囊泡
CN114727947A (zh) 2019-09-25 2022-07-08 科迪亚克生物科学公司 细胞外囊泡组合物
EP4034247A1 (en) 2019-09-25 2022-08-03 Codiak BioSciences, Inc. Sting agonist comprising exosomes for treating neuroimmunological disorders
US20230103726A1 (en) 2019-09-25 2023-04-06 Codiak Biosciences, Inc. Methods of producing extracellular vesicles
JP2022551420A (ja) 2019-09-25 2022-12-09 コディアック バイオサイエンシーズ, インコーポレイテッド 腫瘍を治療するためのil-12提示エクソソームとstingアゴニスト含有エクソソームとの併用
WO2021062057A1 (en) 2019-09-25 2021-04-01 Codiak Biosciences, Inc. Exogenous loading of exosomes via lyophilization
US20230096378A1 (en) 2020-03-12 2023-03-30 Institute For Basic Science Composition for inducing apoptosis of cells having genomic sequence variation and method for inducing apoptosis of cells by using composition
WO2021184020A1 (en) 2020-03-13 2021-09-16 Codiak Biosciences, Inc. Methods of treating neuroinflammation
WO2021184021A1 (en) 2020-03-13 2021-09-16 Codiak Biosciences, Inc. Extracellular vesicle-aso constructs targeting pmp22
WO2021184017A1 (en) 2020-03-13 2021-09-16 Codiak Biosciences, Inc. Extracellular vesicles for treating neurological disorders
JP2023518414A (ja) 2020-03-20 2023-05-01 コディアック バイオサイエンシーズ, インコーポレイテッド 治療のための細胞外小胞
US20230220068A1 (en) 2020-06-05 2023-07-13 Codiak Biosciences, Inc. Anti-transferrin extracellular vesicles
CN116209430A (zh) * 2020-08-07 2023-06-02 阿米库斯治疗学公司 囊泡靶向蛋白及其用途
WO2022066883A1 (en) 2020-09-23 2022-03-31 Codiak Biosciences, Inc. Extracellular vesicles comprising kras antigens and uses thereof
WO2022066928A2 (en) 2020-09-23 2022-03-31 Codiak Biosciences, Inc. Process for preparing extracellular vesicles
US20230366794A1 (en) 2020-09-23 2023-11-16 Codiak Biosciences, Inc. Process for preparing extracellular vesicles
GB202015399D0 (en) * 2020-09-29 2020-11-11 Evox Therapeutics Ltd Engineered extracellular vesicles displaying enhanced pharmacokinetics
WO2022076596A1 (en) 2020-10-06 2022-04-14 Codiak Biosciences, Inc. Extracellular vesicle-aso constructs targeting stat6
CN112410304A (zh) * 2020-11-12 2021-02-26 天津大学 一种基因修饰的外泌体及其制备方法和应用
CN112899307A (zh) * 2021-01-28 2021-06-04 苏州大学 GluN1和/或GluN2亚基羧基末端豆蔻酰化的NMDA受体的应用
JP2024512236A (ja) * 2021-02-17 2024-03-19 ロンザ セールス アーゲー 細胞外ベシクル-nlrp3アンタゴニスト
CA3207950A1 (en) 2021-02-17 2022-08-25 Kimberly ELLIS Methods of loading extracellular vesicles
CA3213989A1 (en) 2021-04-01 2022-10-06 Conlin O'NEIL Extracellular vesicle compositions
CN114057893B (zh) * 2021-04-26 2022-12-30 苏州大学 一种编码线粒体定位的豆蔻酰化多肽及其制备方法与应用
CN117126886A (zh) * 2022-05-20 2023-11-28 谛邈生物科技(北京)有限公司 一种实现工程化EVs功能蛋白模块化装载的核酸构建体及其应用
JP2025521128A (ja) * 2022-05-24 2025-07-08 シフトバイオ インク. 表面改質された細胞外小胞体及びその治療的使用
WO2024215711A1 (en) * 2023-04-10 2024-10-17 Wake Forest University Health Sciences Modified mammalian vesicles and compositions and methods related thereto
CN116769718A (zh) * 2023-04-21 2023-09-19 南京逸微健华生物科技有限公司 一种工程化细胞外囊泡及用途
WO2024226723A1 (en) * 2023-04-26 2024-10-31 Northwestern University Active loading of biomolecular cargo into engineered vesicles
CN118909084A (zh) * 2023-05-08 2024-11-08 天津外泌体科技有限公司 细胞外囊泡支架蛋白及其应用
EP4644537A1 (en) 2024-04-30 2025-11-05 ConvEyXo Targeted extracellular vesicle
WO2025232431A1 (zh) * 2024-05-08 2025-11-13 天津外泌体科技有限公司 筛选影响细胞外囊泡被摄取的基因的系统和方法
WO2026022863A1 (en) * 2024-07-25 2026-01-29 Christian Medical College Extracellular vesicles and uses thereof for targeted delivery
WO2026055342A1 (en) 2024-09-04 2026-03-12 Arsenal Biosciences, Inc. Synthetic pathway activators

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4683195A (en) 1986-01-30 1987-07-28 Cetus Corporation Process for amplifying, detecting, and/or-cloning nucleic acid sequences
PT2254586E (pt) 2008-02-22 2015-05-18 Agency Science Tech & Res Partículas de células estaminais mesenquimais
FR2950350B1 (fr) 2009-09-24 2013-12-13 Centre Nat Rech Scient Nouveaux polynucleotides et polypeptides chimeriques permettant la secretion d'un polypeptide d'interet en association avec des exosomes et leurs utilisations
EP3164420A4 (en) * 2014-06-30 2018-05-23 Tarveda Therapeutics, Inc. Targeted conjugates and particles and formulations thereof
WO2016138525A1 (en) * 2015-02-27 2016-09-01 University Of Washington Polypeptide assemblies and methods for the production thereof
WO2016172598A1 (en) * 2015-04-22 2016-10-27 The Broad Institute Inc. Exosomes and uses thereof
WO2017117585A1 (en) 2015-12-30 2017-07-06 The Regents Of The University Of California Methods for enhanced production and isolation of cell-derived vesicles
US10617768B2 (en) * 2016-07-12 2020-04-14 Santa Clara University Engineered exosomes for the delivery of bioactive cargo using transmembrane tetraspanins
EP3500244B1 (en) * 2016-08-22 2026-07-08 Lonza Sales AG Methods of suppressing delivery of exosomes to liver and spleen
WO2018112154A1 (en) * 2016-12-15 2018-06-21 Codiak Biosciences, Inc. Methods of measuring exosomes using intrinsic fluorescence
KR20240033086A (ko) 2017-08-25 2024-03-12 코디악 바이오사이언시즈, 인크. 막 단백질을 사용한 치료용 엑소좀의 제조
US20190151456A1 (en) * 2017-11-17 2019-05-23 Codiak Biosciences, Inc. Compositions of Engineered Exosomes and Methods of Loading Luminal Exosome Payloads
WO2020041720A1 (en) * 2018-08-24 2020-02-27 Codiak Biosciences, Inc. Extracellular vesicles targeting dendritic cells and uses thereof

Similar Documents

Publication Publication Date Title
JP7295325B2 (ja) ヘテロ二量体、ホモ二量体及び医薬組成物
HRP20220020T1 (hr) Modificirane izvanstanične vezikule i njihova uporaba
US12485184B2 (en) Multimeric T-cell modulatory polypeptides and methods of use thereof
AU2019404285B2 (en) Multimeric T-cell modulatory polypeptides and methods of use thereof
JP2022133308A (ja) キメラアロ抗原受容体t細胞の組成物および方法
KR20180132663A (ko) T-세포 조절 다량체 폴리펩타이드 및 이의 사용 방법
KR20180132070A (ko) T-세포 조절 다량체 폴리펩타이드 및 이의 사용 방법
JP2022515331A (ja) 多量体t細胞調節ポリペプチド及びその使用方法
JP2021532742A5 (cg-RX-API-DMAC7.html)
US20230414777A1 (en) Antigen Presenting Polypeptide Complexes and Methods of Use Thereof
WO2021242935A1 (en) Antigen presenting polypeptide complexes and methods of use thereof
CN117561280A (zh) 携带TGF-β的抗原呈递多肽复合物及其使用方法
US20230218731A1 (en) Antigen Presenting Polypeptide Complexes and Methods of Use Thereof
US20230241192A1 (en) Multimeric t-cell modulatory polypeptides and methods of use thereof
HK40102809A (en) T-cell modulatory multimeric polypeptides and methods of use thereof
HK40102438A (en) T-cell modulatory multimeric polypeptides and methods of use thereof
HK40102439A (en) T-cell modulatory multimeric polypeptides and methods of use thereof
HK40109852A (en) T-cell modulatory multimeric polypeptides and methods of use thereof
HK40102436A (en) T-cell modulatory multimeric polypeptides and methods of use thereof
WO2025056656A1 (en) T-CELL RECEPTOR VARIANT AGAINST mKRAS7-16 G12V
HK40089384A (en) Multimeric t-cell modulatory polypeptides and methods of use thereof
HK40060108B (en) Multimeric t-cell modulatory polypeptides and methods of use thereof